EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

AI Perspectives on the Present and Future of Antidepressant Pharmaceutical Treatment Based on Anti-inflammatory Strategies: A Scoping Review of Randomised Controlled Clinical Trials

Yan Bo, Yifei Chen, Hsu Yi Liang, Fengjiao Zhao, Ming Wu, Youwei Wang, Ren Sha

AI Med · 2025

DOI: 10.71423/aimed.20250103 ↗

Kurz gefasst

Scoping Review in der Zeitschrift AI Med, 2025. Verfasst von Yan Bo und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, a novel concept of 'anti-inflammatory-based pharmacotherapy' has been developed. The aim of this scoping review was precisely to explore in depth the current status of inflammation in randomised controlled clinical trial studies of depression. PubMed was systematically searched from inception to December 11 2024. Studies that researches on the treatment of depression based on anti-inflammatory strategies were included. Study characteristics and outcomes were extracted and organized thematically. 11 reports of randomised controlled clinical trials were included, which accumulated 119 depressed patients. All studies found that there is a connection between the effects of anti-inflammatory drugs in treating depression and a large decrease in the levels of inflammatory markers in the blood of depressed patients compared to before treatment. Three inflammatory markers, CRP, IL-6 and TNF-alpha, were the most frequently mentioned. The current strategy of anti-inflammatory drug administration did not differ fundamentally from the previous strategy of traditional antidepressant drugs combined with psychotherapy. At present, the use of anti-inflammatory strategies for the pharmacological treatment of depression has limited research value and poor feasibility. The potential value and feasibility of future research lies in the application of an integrated AI platform to assist pharmacological treatment of depression based on anti-inflammatory strategies. Registration DOI: https://doi.org/10.17605/OSF.IO/A64GC

Zitieren

APA

Bo, Y., Chen, Y., Liang, H. Y., Zhao, F., Wu, M., Wang, Y., & Sha, R. (2025). AI Perspectives on the Present and Future of Antidepressant Pharmaceutical Treatment Based on Anti-inflammatory Strategies: A Scoping Review of Randomised Controlled Clinical Trials. AI Med. https://doi.org/10.71423/aimed.20250103

Vancouver

Bo Y, Chen Y, Liang HY, Zhao F, Wu M, Wang Y, et al. AI Perspectives on the Present and Future of Antidepressant Pharmaceutical Treatment Based on Anti-inflammatory Strategies: A Scoping Review of Randomised Controlled Clinical Trials. AI Med. 2025. doi:10.71423/aimed.20250103

BibTeX
@article{Bo2025,
  author = {Bo, Yan and Chen, Yifei and Liang, Hsu Yi and Zhao, Fengjiao and Wu, Ming and Wang, Youwei and Sha, Ren},
  title = {AI Perspectives on the Present and Future of Antidepressant Pharmaceutical Treatment Based on Anti-inflammatory Strategies: A Scoping Review of Randomised Controlled Clinical Trials},
  journal = {AI Med},
  year = {2025},
  doi = {10.71423/aimed.20250103}
}
Kostenlos starten →